Neutrophils in the connective tissue are labelled by myeloperoxidase antibody.
Myeloperoxidase (SP72) Rabbit Monoclonal Antibody
Specialties: Hematopathology
Updated: 2018-01-11 09:17:26
Anti-myeloperoxidase detects granulocytes and monocytes in blood and precursors of granulocytes in the bone marrow. This antibody can detect myeloid cell populations of the bone marrow as well as in other sites.1-8
- Pinkus GS, et al. Myeloperoxidase: a specific marker for myeloid cells in paraffin sections. Mod Pathol. 1991; 4:733-41.
- Hudock J, et al. Immunohistochemical evaluation of myeloid leukemia infiltrates (granulocytic sarcomas) in formaldehyde-fixed, paraffin-embedded tissue. Am J Clin Pathol. 1994; 102:55-60.
- Hamoudi WH, et al. Acute myelomonocytic leukemia with histologic features resembling sarcomatoid carcinoma in bone marrow. Arch Pathol Lab Med. 2000; 124:315-8.
- Arber DA, et al. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. Am J Clin Pathol. 1996; 106:462-8.
- Chang CC, et al. Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow. Am J Clin Pathol. 2000; 114:807-11.
- Kaleem Z, et al. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal. Am J Clin Pathol. 2001; 115:876-84.
- Audouin J, et al. Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis. Int J Surg Pathol. 2003; 11:271-82.
- Kojima M, et al. Granulocytic sarcoma presenting with lymph node infarction at disease onset. APMIS. 2003; 111:1133-6.
Specifications
- Reactivity: paraffin
- Control: Bone Marrow (Cytoplasmic); Tonsil (Cytoplasmic)
- Dilution Range: 1:25-1:100*
Package Inserts
IFU
- IVD Rev. 2.0 (CMC28931020)
Have a different keycode?
Click Here
Learn how to obtain your SDS
Ordering Information
For in vitro diagnostic (IVD) use in USA
| 0.1 mL concentrate | 289R-14 |
| 0.5 mL concentrate | 289R-15 |
| 1.0 mL concentrate | 289R-16 |
| 1.0 mL predilute ready-to-use | 289R-17 |
| 7.0 mL predilute ready-to-use | 289R-18 |
For in vitro diagnostic (IVD) use in Canada
| 0.1 mL concentrate | 289R-14 |
| 0.5 mL concentrate | 289R-15 |
| 1.0 mL concentrate | 289R-16 |
| 1.0 mL predilute ready-to-use | 289R-17 |
| 7.0 mL predilute ready-to-use | 289R-18 |
For in vitro diagnostic (IVD) use in Europe
| 0.1 mL concentrate | 289R-14 |
| 0.5 mL concentrate | 289R-15 |
| 1.0 mL concentrate | 289R-16 |
| 1.0 mL predilute ready-to-use | 289R-17 |
| 7.0 mL predilute ready-to-use | 289R-18 |
For research use only (RUO) in Japan
| 0.1 mL concentrate (RUO) | 289R-14-RUO |
| 0.5 mL concentrate (RUO) | 289R-15-RUO |
| 1.0 mL concentrate (RUO) | 289R-16-RUO |
| 1.0 mL predilute ready-to-use (RUO) | 289R-17-RUO |
| 7.0 mL predilute ready-to-use (RUO) | 289R-18-RUO |
To request information on this product in additional countries, please click the button below.